Physician profile
Kathleen Yang
NPI 1013263326
$1,319.77
in general payments reported to CMS, 2019-2025
7 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $54.92 · 2023: $399 · 2024: $591 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099 · Entertainment: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.51 |
| Entertainment | $166.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $569.36 | 2024-2025 | Miebo, Xiidra, Infuse Multifocal |
| New World Medical,INC. | $352.28 | 2023-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Optos, INC. | $166.34 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $102.44 | 2024 | Ce-Marked Kxla System |
| Coopervision INC. | $74.43 | 2024 | Myday Contact Lens |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Carl Zeiss Meditec, INC. | $16.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.